Personalized Glucose Management System with Predictive Analytics and Real-Time Feedback

A wearable glucose monitoring system that integrates machine learning, predictive analytics, and real-time feedback to provide personalized glucose management and alert users of potential hypoglycemic events.

The original patent's limitation lies in its reliance on acceleration data to generate alerts, which may not accurately reflect glucose levels. This new inventive concept addresses this limitation by incorporating machine learning algorithms, user behavior patterns, and environmental factors to provide more accurate and personalized glucose management.

The system comprises a wearable glucose sensor, a machine learning module, a personalized alert module, and a neural interface. The machine learning module predicts hypoglycemic events based on glucose data, user behavior patterns, and environmental factors. The personalized alert module generates customized alerts for the user based on the predicted events. The neural interface provides real-time feedback to the user, enabling proactive glucose management. The system can be integrated with virtual assistants for voice-based notifications, and social sharing features can be added for sharing glucose data with healthcare professionals.

The new claims introduce the novel concept of integrating machine learning, predictive analytics, and real-time feedback to provide personalized glucose management. This inventive step lies in the use of machine learning algorithms to analyze user behavior patterns and environmental factors, enabling more accurate predictions of hypoglycemic events.

Alternative embodiments may include using non-invasive glucose sensors, cloud-based analytics platforms, or blockchain-based data storage systems. Variations may include integrating the system with wearable devices, such as smartwatches, or developing mobile applications for personalized glucose insights and alerts.

This inventive concept has significant commercial potential in the healthcare industry, particularly in the diabetes management market. The system can be marketed as a premium product for individuals with diabetes, offering a more accurate and personalized glucose management solution.